Calcium release activity and metabolism of inositol 1,4,5‐trisphosphate in T cells
- 1 June 1994
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 222 (2) , 515-523
- https://doi.org/10.1111/j.1432-1033.1994.tb18893.x
Abstract
Stimulation of the T cell antigen receptor/CD3 complex is followed by phospholipase C activation, phosphoinositol lipid metabolism and ultimately by a rapid rise in both myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] and myo-inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4] as well as cytosolic free calcium concentration. A 5-phosphatase plays a pivotal role in the subsequent metabolism of Ins(1,4,5)P3 and Ins(1,3,4,5)P4. Synthetic routes have been developed which have enabled the synthesis of both natural and unnatural inositol phosphates and this approach has yielded several compounds which have been shown to act as inhibitors of Ins(1,4,5)P3 5-phosphatase. These compounds offer considerable potential for investigation of the complex metabolism and function of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in T cell activation and proliferation. We now report the time course and temperature sensitivity of Ins(1,4,5)P3-induced 45Ca2+ release in the permeabilised leukaemic T cell line Jurkat. Furthermore, we demonstrate that the metabolism of Ins(1,4,5)P3 in the presence of two novel 5-phosphatase inhibitors, namely L-myo-inositol 1,4,5-trisphosphorothioate [L-Ins(1,4,5)PS3] and myo-inositol 1,3,5-trisphosphorothioate [Ins(1,3,5)PS3], can be inhibited with concomitant elevation of the heparin-sensitive Ins(1,4,5)P3-induced release of 45Ca2+. These novel 5-phosphatase inhibitors provide a starting point for development of cell-permeable analogues which may be able to modulate cell function in intact cells and may be used as manipulative tools with which to elucidate the function of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 with respect to T cell activation.Keywords
This publication has 36 references indexed in Scilit:
- Synthesis of Selective Non-Ca2+ Mobilizing Inhibitors of D-myo-Inositol 1,4,5-Trisphosphate 5-PhosphataseJournal of Medicinal Chemistry, 1994
- Inositol trisphosphate and calcium signallingNature, 1993
- Synthesis of L-chiro-inositol 1,4,6-trisphosphorothioate, a potent and selective inhibitor of myo-inositol 1,4,5-trisphosphate 5-phosphataseBioorganic & Medicinal Chemistry Letters, 1992
- The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesteraseClinical and Experimental Immunology, 1992
- Regulation of D‐3 phosphoinositides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigensEuropean Journal of Immunology, 1992
- Stimulation of the phosphatidyl-inositol pathway can induce T-cell activationNature, 1990
- Regulation of calcium influx across the plasma membrane of the human T-leukemic cell line, JURKAT: Dependence on a rise in cytosolic free calcium can be dissociated from formation of inositol phosphatesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Dissociation of unidirectional influx of external Ca2+ and release frominternal stores in activated human T lymphocytes*European Journal of Immunology, 1990
- myo‐Inositol 1,4,5‐trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5‐phosphataseFEBS Letters, 1989
- Failure to synthesize the T Cell CD3-? chain: Structure and function of a partial T cell receptor complexCell, 1988